MENLO PARK, Calif., March 07, 2017 -- Landec Corporation (NASDAQ:LNDC), a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets, announced today that the Company's recently acquired business, O Olive Oil, Inc. ("O Olive"), will participate at the Natural Products Expo West trade show. Landec's President and Chief Executive Officer Molly Hemmeter will be joining Greg Hinson, Founder and President of O Olive, along with other Company representatives from Landec and Apio at the largest natural, organic and healthy products conference in the world.
The Natural Products Expo West 2017 trade show will be held from March 8, 2017 to March 12, 2017 at the Anaheim Convention Center in Anaheim, CA. It is the leading trade show in the natural, organic and healthy products industry and was rated as one of the top 200 trade shows in the United States by Tradeshow Week. More than 3,000 exhibitors from nearly 125 different countries participated in last year's event. Last year, more than 75,000 visitors attended the event, up from just 3,000 visitors at its inaugural event in 1981.
As previously reported on March 1, 2017, Landec entered into a definitive agreement to purchase O Olive. The Company was founded in 1995, is based in Petaluma, California, and is the premier producer of California specialty olive oils and wine vinegars. O Olive has been honored with 17 SOFI awards by the Specialty Food Association, more than any other oil and vinegar company in the world. Its products are sold in over 4,600 natural food, conventional grocery and mass retail stores, primarily in the United States and Canada.
For additional information on O Olive, please visit their website at: www.ooliveoil.com
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets. Apio, Landec’s food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
Contact Information: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: John Mills, Partner (646) 277-1254 [email protected]


Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 



